Purple Biotech Ltd Net Income per Employee (PPBT), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Purple Biotech Ltd  (NASDAQ: PPBT)
 

Purple Biotech Ltd Net Income per Employee

PPBT's Quarterly Results, Trends, Rankings, Statistics
Purple Biotech Ltd's Income per employee fell in the fourth quarter 2024 on a trailing twelve month basis to $ 1,819,750, below the company average number of $3,626,792.
The Healthcare sector has seen employees of 7 other companies achieving higher income per employee. While Purple Biotech Ltd's total ranking has deteriorated compared to the previous quarter from to 132.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PPBT Net Income per Employee (Dec 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Net Income Change -66.55 % - - - 17.83 %
Net Income per Employee (TTM) $ 1,819,750 5,440,000 5,440,000 5,440,000 5,440,000
PPBT's Total Ranking # 132 # # # #
Seq. Net Income Change - - - - -

PPBT Company Profile >> Back to PPBT Efficiency Comparisons >> Compare PPBT Net Income per Employee to its Competitors

PPBT Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 8
Healthcare Sector # 12
Overall Market # 132

Net Income per Employee Statistics
High Average Low
$ 7,018,500 $ 3,626,792 $ 1,392,250
(Dec 31 2020)   (Dec 31 2018)







Companies with similar Income per Employee for 12 month ending Dec 31 2024, within Healthcare Sector Income per Employee Income 12 month ending Dec 31 2024Number of Employees Dec 31 2024
Traws Pharma inc   2,792,058.82 $ 47.465  Million 17 
Sanofi  2,757,300.61 $ 6,292.160  Million 2,282 
Vystar Corporation  2,520,312.00 $ 2.520  Million 1 
Protagonist Therapeutics inc   2,084,757.58 $ 275.188  Million 132 
Alumis inc   1,540,196.43 $ 345.004  Million 224 
Glucotrack Inc   1,506,466.67 $ 22.597  Million 15 
Novo Nordisk A  1,452,960.22 $ 100,988.000  Million 69,505 
Semler Scientific inc   1,319,322.58 $ 40.899  Million 31 
Agios Pharmaceuticals Inc   1,247,638.89 $ 673.725  Million 540 
Siga Technologies Inc  1,208,453.39 $ 59.214  Million 49 
Tenax Therapeutics Inc   1,100,125.00 $ 17.602  Million 16 
Halozyme Therapeutics Inc   1,049,860.52 $ 444.091  Million 423 
Exelixis Inc   1,048,741.94 $ 1,202.907  Million 1,147 
Scienture Holdings Inc   1,007,310.89 $ 9.066  Million 9 


Date modified: 2026-09-02T18:44:22+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.